+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Thrombocytopenia as a Prognostic Marker for Systemic Lupus Erythematosus: A Systematic Review and Meta-analysis



Thrombocytopenia as a Prognostic Marker for Systemic Lupus Erythematosus: A Systematic Review and Meta-analysis



American Journal of the Medical Sciences 2019



Systemic lupus erythematosus (SLE) patients often exhibit hematological abnormalities, but the role of thrombocytopenia on the prognosis of SLE shows inconsistent results. The purpose of this meta-analysis was to confirm the impact of thrombocytopenia on mortality and end organ damage in patients with SLE. Three electronic databases, PubMed, Embase and Cochrane library were systematically searched to identify the eligible studies from inception to November 2017 in order to evaluate the impact of thrombocytopenia on the prognosis of patients with SLE. The summary odds ratios (ORs) and 95% confidence intervals (CIs) were used to measure the impact of thrombocytopenia on mortality and end organ damage based on the random-effects model. A total of 8 studies that reported data on 2,158 patients with SLE were included. The summary OR indicated that SLE subjects with thrombocytopenia were significantly associated with an increased risk of mortality (OR: 4.57; 95% CI: 2.28-9.17; P < 0.001) and end-organ damage (OR: 3.31; 95% CI: 1.11-9.86; P = 0.031). Furthermore, the sensitivity analysis indicated stable mortality, while the result for end organ damage was variable. In addition, the patients with thrombocytopenia with disease duration <60 months presented a greater risk for mortality than those with disease duration ≥60.0 months (P = 0.002). Patients with SLE and thrombocytopenia were found to be associated with an increased risk of mortality and end organ damage.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 066693650

Download citation: RISBibTeXText

PMID: 30987767

DOI: 10.1016/j.amjms.2019.03.002


Related references

Survival and prognostic factors of systemic lupus erythematosus-associated pulmonary arterial hypertension: A PRISMA-compliant systematic review and meta-analysis. Autoimmunity Reviews 15(3): 250-257, 2016

Anti-cyclic citrullinated peptide antibody as a marker of erosive arthritis in patients with systemic lupus erythematosus: a systematic review and meta-analysis. Lupus 23(11): 1156-1163, 2015

A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clinical Journal of the American Society of Nephrology 5(11): 2060-2068, 2011

Association between Systemic Lupus Erythematosus and Periodontitis: A Systematic Review and Meta-analysis. Frontiers in Immunology 8: 1295, 2017

Rituximab in systemic lupus erythematosus: an updated systematic review and meta-analysis. Lupus 22(14): 1489-1503, 2014

Associations between TLR polymorphisms and systemic lupus erythematosus: a systematic review and meta-analysis. Clinical and Experimental Rheumatology 30(2): 262-265, 2012

Foot and ankle characteristics in systemic lupus erythematosus: A systematic review and meta-analysis. Seminars in Arthritis and Rheumatism 2018, 2018

Assessment of subclinical atherosclerosis in systemic lupus erythematosus: A systematic review and meta-analysis. Joint, Bone, Spine 85(2): 155-163, 2017

Prevalence of depression and anxiety in systemic lupus erythematosus: a systematic review and meta-analysis. Bmc Psychiatry 17(1): 70, 2017

SAT0446The prevalence of systemic lupus erythematosus in europe: A systematic review and meta-analysis. Annals of the Rheumatic Diseases 71(Suppl 3): 623.1-623, 2013

SAT0389Assessment of Subclinical Atherosclerosis in Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis. Annals of the Rheumatic Diseases 74(Suppl 2): 800.2-800, 2015

Smoking and the risk of systemic lupus erythematosus: an updated systematic review and cumulative meta-analysis. Clinical Rheumatology 34(11): 1885-1892, 2016

THU0344Osteoporosis and Vertebral Fractures in Patients with Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis. Annals of the Rheumatic Diseases 75(Suppl 2): 311.2-312, 2016

Efficacy and safety of rituximab therapy for systemic lupus erythematosus: a systematic review and meta-analysis. Journal of Zhejiang University. Science. B 13(9): 731-744, 2013

Intravenous immunoglobulin in the therapeutic armamentarium of systemic lupus erythematosus: a systematic review and meta-analysis. Medicine 93(16): E86, 2014